Secondary metabolites of Hypericum scabrum and Hypericum bupleuroides

References

• Ayan A, Çırak C, Kevseroğlu K, Özen T (2004): Hypericin in some Hypericum species from Turkey. Asian J Plant Sci 3: 200–202.
   Google Scholar
• Ayan AK, Çırak C, Güney K (2008): Seasonal variation of hypericin and pseudohypericin contents in Hypericum scabrum L. growing wild in Turkey. Nat Prod Commun 3: 241–244.
   Web of Science ®Google Scholar
• Ayan AK, Çırak C (2008): Hypericin and pseudohypericin contents in some Hypericum species growing in Turkey. Pharm Biol 46: 288–291.
   Web of Science ®Google Scholar
• Azırak S, Erdoğrul öT, (2003): Antibacterial activities of Hypericum scabrum. ISOPS-7: International Symposium on Pharmaceutical Sciences-7, Ankara University, Faculty of Pharmacy Publications, No: 87. Proceedings and Abstracts, June 23-26, Ankara, Turkey, pp. 17–21.
   Google Scholar
• Bauer S, Störmer E, Graubaum HJ, Roots I (2001): Determination of hyperforin, hypericin, and pseudohypericin in human plasma using high-performance liquid chromatography analysis with fluorescence and ultraviolet detection. J Chromatogr B 765: 29–35.
   PubMed Web of Science ®Google Scholar
• Baytop T (1999): Therapy with Medicinal Plants in Turkey. Istanbul, Istanbul University Press, pp. 66–167.
   Google Scholar
• Chu YH, Chang CL, Hsu HF (2000): Flavonoid content of several vegetables and their antioxidant activity. J Sci Food Agric 80: 561–566.
   Web of Science ®Google Scholar
• Ciccarelli D, Andreucci AC, Pagni AM (2001): Translucent glands and secretory canals in Hypericum perforatum. Morphological, anatomical and histochemical studies during the course of onthogenesis. Ann Bot 88: 637–644.
   Web of Science ®Google Scholar
• Çırak C, Saglam B, Ayan AK, Kevseroglu K (2006): Morphogenetic and diurnal variation of hypericin in some Hypericum species from Turkey during the course of ontogenesis. Biochem Syst Ecol 34: 1–13.
   Web of Science ®Google Scholar
• Çırak C, Radušienė J, Janulis V, Ivanauskas L (2007a): Variation of bioactive secondary metabolites in Hypericum origanifolium during its phenological cycle. Acta Physiol Plant 29: 197–203.
   Web of Science ®Google Scholar
• Çırak C, Radušienė J, Karabük B, Janulis V, Ivanauskas L (2007b): Variation of bioactive compounds in Hypericum perforatum growing in Turkey during its phenological cycle. J Integr Plant Biol 49: 615–620.
   Web of Science ®Google Scholar
• Çırak C, Radušienė J (2007): Variation of hyperforin in Hypericum montbretii during its phenological cycle. Nat Prod Res 21: 1151–1156.
   PubMed Web of Science ®Google Scholar
• DAC (Deutscher Arzneimittel Codex-German Pharmaceutical Codex) (1986): Ergänzung zum Arzneibuch, Frankfurt am Main, Govi Verlag, (in der Ergänzung von 1991).
   Google Scholar
• Davis PH (1988): Flora of Turkey and the East Aegean Islands. Edinburgh, Edinburgh University Press, pp. 266–400.
   Google Scholar
• Demirci B, Başer KHC, Crockett S, Khan IA (2005): Analyses of the volatile constituents of Asian Hypericum L. species. J Essent Oil Res 17: 659–663.
   Web of Science ®Google Scholar
• Dona M, Dell’Aica I, Pezzato E, Sartor L, Calabrese F, Della Barbera M, Donella-Deana A, Appendino G, Borsarini A, Caniato R, Garbisa S (2004): Hyperforin inhibits cancer invasion and metastasis. Cancer Res 64: 6225–6232.
   PubMed Web of Science ®Google Scholar
• EDQM (2004): St. John’s Wort Dry Extract, Quantified. Strasbourg, European Directorate for the Quality of Medicines Press, pp. 97–98.
   Google Scholar
• Erdoğrul öT, Azırak S, Tosyalı C (2004): Antimicrobial activities of Hypericum scabrum L. extracts. KSU J Sci Eng 7: 38–42.
   Google Scholar
• Feisst C, Werz O (2004): Suppression of receptor-mediated Ca2+ mobilization and functional leukocyte responses by hyperforin. Biochem Pharmacol 67: 1531–1539.
   PubMed Web of Science ®Google Scholar
• Gastpar M, Zeller K (2005): Hypericum-extrakt STW3 und Sertralin zur Behandlung der mittelschweren depression. Psychopharmakotherapie– Efficacy and tolerability of hypericum extract STW3 in long-term treatment with a once-daily dosage in comparison with sertraline. 12: 146–153.
   Google Scholar
• Greeson J, Sanford B, Monti DA (2001): St. John’s wort (Hypericum perforatum): A review of the current pharmacological, toxicological and clinical literature. Psychopharmacol 153: 402–414.
   PubMed Web of Science ®Google Scholar
• Guedes RC, Eriksson LA (2005): Theoretical study of hypericin. J Photochem Photobiol A: Chem 172: 293–299.
   Web of Science ®Google Scholar
• Kazlauskas S, Bagdonaite E (2004): Quantitative analysis of active substances in St. John’s wort (Hypericum perforatum L.) by the high performance liquid chromatography method. Medicina (Kaunas) 40: 975–981.
   PubMedGoogle Scholar
• Kirakosyan A, Gibson D, Sirvent T (2003): Comparative survey of Hypericum perforatum plants as sources of hypericins and hyperforin. J Herbs Species Med Plants 10: 110–122.
   Google Scholar
• Kitanov GM (2001): Hypericin and pseudohypericin in some Hypericum species. Biochem Syst Ecol 29: 171–178.
   PubMed Web of Science ®Google Scholar
• Kurth H, Spreemann R (1998): Phytochemical characterization of various St. John’s wort extracts. Adv Ther 15: 117–128.
   PubMed Web of Science ®Google Scholar
• Maggi F, Ferretti G, Pocceschi N, Menghini L, Ricciutelli M (2004): Morphological, histochemical and phytochemical investigation of the genus Hypericum of central Italy. Fitoterapia 75: 702–711.
   PubMed Web of Science ®Google Scholar
• Martonfi P, Repcak M (1994): Secondary metabolites during flower ontogenesis of Hypericum perforatum L. Zahradnictvi 21: 37–44.
   Google Scholar
• Michelitsch A, Biza B, Wurglics M, Schubert-Zsilavecz M, Baumeister A, Likussar W (2000): Determination of hypericin in herbal medicine products by differential pulse polarography. Phytochem Anal 11: 41–44.
   Web of Science ®Google Scholar
• Noldner M, Schotz K (2002): Rutin is essential for the antidepressant activity of Hypericum perforatum extracts in the forced swimming test. Planta Med 68: 577–580.
   PubMed Web of Science ®Google Scholar
• Patocka J (2003): The chemistry, pharmacology, and toxicology of the biologically active constituents of the herb Hypericum perforatum L. J Appl Biomed 1: 61–73.
   Google Scholar
• Radusiene J, Bagdonaite E, Kazlauskas S (2004): Morphological and chemical evaluation of Hypericum perforatum and H. maculatum in Lithuania. Acta Hort (ISHS) 629: 55–62.
   Google Scholar
• Roz N, Rehavi M (2004): Hyperforin depletes synaptic vesicles content and induces compartmental redistribution of nerve ending monoamines. Life Sci 75: 2841-2850.
   PubMed Web of Science ®Google Scholar
• Schwarz D, Kisselev P, Roots I (2003): St. John’s wort extracts and some of their constituents potently inhibit ultimate carcinogen formation from benzo[a]pyrene-7,8-dihydrodiol by human CYP1A1. Cancer Res 63: 8062–8068.
   PubMed Web of Science ®Google Scholar
• Sirvent T, Walker L, Vance N, Donna G (2002): Variation in hypericins from wild populations of Hypericum perforatum L. in the Pacific northwest of the USA. Econ Bot 56: 41–49.
   Web of Science ®Google Scholar
• Southwell IA, Bourke CA (2001): Seasonal variation in hypericin content of Hypericum perforatum L. (St. John’s wort). Phytochemistry 56: 437–441.
   PubMed Web of Science ®Google Scholar
• Tanker N (1971): Studies on Hypericum scabrum L. J Fac Pharm Ankara Univ 1: 10–15.
   Google Scholar
• Walker L, Sirvent T, Gibson D, Vance N (2001): Regional differences in hypericin and pseudohypericin concentrations and five morphological traits among Hypericum perforatum plants in the north-western United States. Can J Bot 79: 1248–1255.
   Google Scholar
• Zevakova VA, Glyzin VI, Shemeryankina TV, Patudin AV (1991): HPLC determination of hypericins in species of St. John’s wort. Khim Prir Soedin 27: 138–141.
   Google Scholar